Impact of COVID-19 on prescribing patterns and treatment selection of disease modifying therapies in multiple sclerosis

BACKGROUND: Certain classes of multiple sclerosis (MS) disease modifying therapies (DMTs) have been associated with an increased risk of severe COVID-19, resulting in prescribers considering changes in their practice habits during the COVID-19 pandemic. This study assessed for differences in prescri...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaheer, Reemal, Amin, Roma, Riddick, LaTasha, Roy, Shuvro, Wolff, Sujin, Nathanson, Amy, Newsome, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924032/
https://www.ncbi.nlm.nih.gov/pubmed/36857853
http://dx.doi.org/10.1016/j.msard.2023.104575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924032/
https://www.ncbi.nlm.nih.gov/pubmed/36857853
http://dx.doi.org/10.1016/j.msard.2023.104575

Ejemplares similares